Akèy › Tit travay › Biostatistician II
Biostatistician II: Salè H-1B
160 aplikasyon kondisyon travay te itilize tit travay Biostatistician II. Salè baz medyàn ofri $94,723; mwatye mitan $85,177–$107,340.
Demann (LCA)160
Salè medyan ofri$94,723
Mwatye salè yo$85,177–$107,340
10yèm–90yèm pousantaj$76,910–$130,000
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| Duke University | 15 | $91,059 |
| Medpace, Inc. | 11 | $144,000 |
| Icahn School of Medicine at Mount Sinai | 10 | $90,313 |
| Medical College of Wisconsin, Inc. | 8 | $86,218 |
| Frontier Science and Technology Research Foundation Inc. | 6 | $96,010 |
| University of Utah | 6 | $76,508 |
| Beth Israel Deaconess Medical Center, Inc. | 6 | $65,280 |
| Foundation Medicine, Inc. | 5 | $104,416 |
| Everest Clinical Research Corporation | 5 | $120,000 |
| PPD Development, L.P. | 5 | $97,157 |
| Syneos Health, LLC | 4 | $107,217 |
| Parexel International LLC | 4 | $111,076 |
| Fortrea Inc. | 4 | $103,938 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 3 | $90,000 |
| Children's Hospital Corporation | 3 | $91,333 |
| Hennepin Healthcare Research Institute | 3 | $74,402 |
| University of Wisconsin System | 3 | $77,326 |
| Predicine, Inc. | 3 | $114,400 |
| Tempus AI | 3 | $131,300 |
| Mount Sinai Hospital | 3 | $81,500 |
| Saint Luke's Health System | 2 | $94,795 |
| Public Health Institute | 2 | $105,510 |
| Beckman Coulter, Inc. | 2 | $89,954 |
| University of Massachusetts Chan Medical School | 2 | $69,000 |
| Children's Hospital Los Angeles | 2 | $101,566 |
| Fred Hutchinson Cancer Center | 2 | $95,000 |
| The University of Texas Health Science Center at Houston | 2 | $88,970 |
| Fortrea Clinical Research Unit Inc. | 2 | $99,663 |
| Prometrika LLC | 2 | $111,024 |
| New York Society for Relief of Ruptured & Crippled | 2 | $96,106 |
| Henry Ford Health System | 2 | $79,212 |
| The University of Southern California | 2 | $58,843 |
| Boston Scientific Corporation | 2 | $101,548 |
| University of Massachusetts Lowell | 1 | $61,200 |
| QPS, LLC | 1 | $86,293 |
| H. Lee Moffitt Cancer Center & Research Institute, Inc. | 1 | $86,570 |
| WCG Clinical, Inc. | 1 | $78,936 |
| Labcorp Clinical Research Unit Inc. | 1 | $61,755 |
| Saint Louis | 1 | $80,000 |
| Clindata Insight Inc. | 1 | $137,500 |
| Sumitomo Pharma America, Inc. | 1 | $132,670 |
| Axio Research, LLC | 1 | $110,000 |
| Baylor University Medical Center | 1 | $105,347 |
| Dignity Health | 1 | $84,635 |
| Baylor Research Institute | 1 | $110,000 |
| Celerion, Inc. | 1 | $103,376 |
| University of Mississippi Medical Center | 1 | $75,292 |
| Tufts University | 1 | $90,000 |
| The University of Arizona | 1 | $82,000 |
| Pharmaceutical Research Associates, Inc. | 1 | $102,628 |
| Fortrea Inc. f/k/a LabCorp Drug Development Inc. | 1 | $120,000 |
| Edwards Lifesciences LLC | 1 | $110,822 |
| The Research Institute at Nationwide Children's Hospital | 1 | $85,000 |
| Wake Forest University Baptist Medical Center | 1 | $81,702 |
| University of Louisville | 1 | $83,538 |
| Abbott Diabetes Care Inc. | 1 | $105,000 |
| TechData Service Company LLC | 1 | $114,000 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $86,676 |
| Nivo II (kalifye) | $98,626 |
| Nivo III (eksperyans) | $122,372 |
| Nivo IV (plen kompetans) | $110,002 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 41 | $90,000 |
| FY2024 | 40 | $102,950 |
| FY2025 | 46 | $97,054 |
| FY2026 | 32 | $97,005 |
Vil yo
- Durham, NC18
- New York, NY14
- Boston, MA12
- Cincinnati, OH10
- Milwaukee, WI8
- Salt Lake City, UT6
- Madison, WI5
- Jersey City, NJ5
- Torrance, CA3
- Minneapolis, MN3
- Hayward, CA3
- Los Angeles, CA3
- Cambridge, MA3
- Kansas City, MO2
- Fort Lee, NJ2
- Worcester, MA2
- Houston, TX2
- Bridgewater, NJ2
- Dallas, TX2
- Seattle, WA2
- Cary, NC2
- Detroit, MI2
- Alexandria, VA2
- Minnetonka, MN2
- Menlo Park, CA1
- Lowell, MA1
- Baltimore, MD1
- Emeryville, CA1
- Blue Bell, PA1
- Newark, DE1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).